期刊文献+

原发性肝癌合并肝源性糖尿病的治疗方法及预后相关因素分析 被引量:1

Therapy and prognostic features of primary hepatocellular carcinoma with hepatogenous diabetes
下载PDF
导出
摘要 目的探讨原发性肝癌合并肝源性糖尿病(PHCHD)的治疗方法,并分析其预后影响因素。方法 68例PHCHD患者均行手术切除治疗,其中肝大部切除19例,半肝切除13例,次半肝切除36例;术后单纯皮下注射胰岛素46例,胰岛素皮下注射加阿卡波糖口服22例。采用Kaplan-Meier法分析患者的临床资料与生存时间的关系,采用COX多因素回归分析PHCHD预后相关因素。结果本组中位生存期32个月,1、3、5 a生存率为76.13%、47.36%、36.12%。血清HCVAb、Child-Pugh分级、TNM分期、肝硬化、门脉瘤栓、血管侵犯与患者生存时间有关(P均<0.05);肝硬化、血管侵犯、门脉瘤栓与患者的预后有关(P均<0.05)。结论手术切除和胰岛素皮下注射是治疗PHCHD的有效方法;肝硬化、血管侵犯、门脉瘤栓是影响PHCHD患者预后的独立危险因素。 Objective To explore the therapeutic strategies and prognosis factors of primary hepatocellular carcinoma with hepatogenous diabetes(PHCHD).Method The clinical pathological data of 68 patients with PHCHD treated with hepatectomy were analized retrospectively.Results All 68 patients underwent surgical tumor resection.Anatomical resection included segmentectomy 19 cases,hemi-hepatectomy 13 cases and sub-segmentectomy 36 cases.Single insulin treatment group was 46 cases,the acarbose and insulin treatment gtoup was 22 cases.Median survival period of the PHCHD was 32 months.1,3 and 5 years survival rates were 76.13%,47.36%,36.12%.The Kaplan-Meier method showed that serum HCVAb,Child-Pugh classification,TNM staging,liver cirrhosis,vascular invasion and portal vein embolus were related to survival.Cox regression analysis showed that liver cirrhosis,portal vein embolus and vascular invasion were independent risk factors for overall survival.Conclusions The surgery and insulin treatment are most effective modality for the patients with PHCHD.Liver cirrhosis,portal vein embolus and vascular invasion are independent risk factors for prognosis of PHCHD.
作者 吉胜朴 李强
出处 《山东医药》 CAS 北大核心 2011年第14期11-12,共2页 Shandong Medical Journal
基金 国家自然科学基金资助项目(30772467)
关键词 肝肿瘤 原发性肝癌 肝源性糖尿病 胰岛素 生存分析 liver neoplasm primary hepatocellular carcinoma hepatocellular carcinoma insulin survival analysis
  • 相关文献

参考文献1

二级参考文献14

  • 1Kazuhiko Koike,Kyoji Moriya.Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH[J].Journal of Gastroenterology.2005(4)
  • 2Vlad Ratziu MD, JB,Jean-Baptiste Trabut MD,Thierry Poynard MD, PhD.Fat, diabetes, and liver injury in chronic hepatitis C[J].Current Gastroenterology Reports.2004(1)
  • 3Shivakumar Chitturi MD,Jacob George MD.Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis[J].Current Gastroenterology Reports.2003(1)
  • 4D. R. Matthews,J. P. Hosker,A. S. Rudenski,B. A. Naylor,D. F. Treacher,R. C. Turner.Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man[J].Diabetologia.1985(7)
  • 5Papatheodoridis GV,Chrysanthos N,Savvas S,Sevastianos V,Kafiri G,Petraki K,Manesis EK.Diabetes mellitus in chronic hepatitis B and C:prevalence and potential association with the extent of liver fibrosis[].Journal of Viral Hepatitis.2006
  • 6Chen HF,Li CY,Chen P,See TT,Lee HY.Seroprevalence of hepatitis B and C in type 2 diabetic patients[].Journal of the Chinese Medical Association.2006
  • 7Mangia A,Schiavone G,Lezzi G,Marmo R,Bruno F,Villani MR,Cascavilla I,Fantasia L,Andriulli A.HCV anddiabetes mellitus:evidence for a negative association[].The American journal of Gastroenterology.1998
  • 8Prati D,Shiffman ML,Diago M,Gane E,Rajender Reddy K,Pockros P,Farci P,O’Brien CB,Lardelli P,Blotner S,Zeuzem S.Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C[].Journal of Hepatology.2006
  • 9Mehta SH,Brancati FL,Sulkowski MS,et al.Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States[].Annals of Internal Medicine.2000
  • 10Zein N N,Abdulkarim A S,Wiesner R H,et al.Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease[].Journal of Hepatology.2000

共引文献7

同被引文献17

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部